Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression, Disease”

3,448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,448 results

Large-scale testing (Phase 3)Ended earlyNCT01416181
What this trial is testing

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Biogen 889
Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265
What this trial is testing

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate Carcinoma
M.D. Anderson Cancer Center 310
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableStudy completedNCT01282931
What this trial is testing

Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Health Outcomes Solutions 200
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Post-approval studies (Phase 4)Study completedNCT01023607
What this trial is testing

Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS)

Who this might be right for
Coronary Artery DiseaseHyperlipidemia
Harbin Medical University 120
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Not applicableWithdrawnNCT03103464
What this trial is testing

Sit-to-Stand Progression Using Movi Chair vs Traditional Practices

Who this might be right for
Physical Activity
University of Alabama at Birmingham
Large-scale testing (Phase 3)Active Not RecruitingNCT03164616
What this trial is testing

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

Who this might be right for
Non Small Cell Lung Cancer NSCLC
AstraZeneca 1,186
Large-scale testing (Phase 3)Looking for participantsNCT07281833
What this trial is testing

Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment

Who this might be right for
Breast CancerHR-positive Breast CancerAdvanced Breast Cancer+2 more
West German Study Group 250
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Post-approval studies (Phase 4)Not Yet RecruitingNCT07004335
What this trial is testing

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

Who this might be right for
PD-(L)1CTLA-4Advanced Melanoma+3 more
Hebei Medical University Fourth Hospital 40
Not applicableUnknownNCT01860508
What this trial is testing

PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

Who this might be right for
Non-small Cell Lung Cancer
Fudan University 94
Not applicableUnknownNCT02379208
What this trial is testing

Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Turku University Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04738292
What this trial is testing

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
University of Wisconsin, Madison 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334
What this trial is testing

Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 39
Not applicableLooking for participantsNCT05138393
What this trial is testing

Scoliosis-specific Exercises for Mild Idiopathic Scoliosis

Who this might be right for
Idiopathic Scoliosis
Karolinska Institutet 90
Testing effectiveness (Phase 2)Study completedNCT03544814
What this trial is testing

EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression

Who this might be right for
Lung AdenocarcinomaEGFR Activating Mutation
Shanghai Chest Hospital 99
Load More Results